作者
Walter Ageno, Alfredo Farjat, Sylvia Haas, Jeffrey I Weitz, Samuel Z Goldhaber, Alexander GG Turpie, Shinya Goto, Pantep Angchaisuksiri, Joern Dalsgaard Nielsen, Gloria Kayani, Sebastian Schellong, Henri Bounameaux, Lorenzo G Mantovani, Paolo Prandoni, Ajay K Kakkar
发表日期
2021/2/1
期刊
Research and practice in thrombosis and haemostasis
卷号
5
期号
2
页码范围
326-341
出版商
Elsevier
简介
Introduction
Venous thromboembolism (VTE) has a long‐term risk of recurrence, dependent on the presence or absence of provoking risk factors at the time of the event.
Objective
To compare clinical characteristics, anticoagulant patterns, and 12‐month outcomes in patients with transient provoking factors, active cancer, and unprovoked VTE.
Methods
The Global Anticoagulant Registry in the FIELD (GARFIELD)‐VTE is a prospective, observational study that enrolled 10 207 patients with objectively diagnosed VTE from 415 sites in 28 countries.
Results
Patients with transient provoking factors were younger (53.0 years) and more frequently women (61.2%) than patients with unprovoked VTE (60.3 years; 43.0% women) or active cancer (63.6 years; 51.7% women). After 6 months, 59.1% of patients with transient provoking factors remained on anticoagulation, compared to 71.3% with unprovoked VTE and 47.3% with …
学术搜索中的文章
W Ageno, A Farjat, S Haas, JI Weitz, SZ Goldhaber… - Research and practice in thrombosis and haemostasis, 2021